DiStefano, PhD, at cuanschutz.edu
British Journal of Psychiatry 167, 99103.CrossRefGoogle ScholarPubMed Suchankova, P, Yan, J, Schwandt, ML, Stangl, BL, Caparelli, EC, Momenan, R, Jerlhag, E, Engel, JA, Hodgkinson, CA, Egli, M and Lopez, MF (2015) The glucagon-like peptide-1 receptor as a potential treatment target in alcohol use disorder: evidence from human genetic association studies and a mouse model of alcohol dependence
Other Names for This Condition CACT deficiency Carnitine acylcarnitine translocase deficiency Carnitine-acylcarnitine carrier deficiency Additional Information & Resources Genetic Testing Information Genetic and Rare Diseases Information Center Patient Support and Advocacy Resources Clinical Trials Catalog of Genes and Diseases from OMIM Scientific Articles on PubMed References Geven WB, Niezen-Koning KE, Timmer A, van Loon AJ, Wanders RJ, van Spronsen FJ
By comparison, the average percentage of employees in the U.S
Before your first injection, map out your complete schedule from starting dose through target maintenance dose
